Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy
Clinical trial NCT04555304 · UNKNOWN
Trial details
- NCT number
- NCT04555304
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2022-01-15
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.